The University of Florida was awarded a $5.796 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of September 1, 2023 through August 31, 2027. The grant will support the development of clinical candidates for the treatment of Myotonic Dystrophy at the University's location in Gainesville, Florida. As the prime awardee, the University will leverage its expertise in biomedical research to investigate medical solutions and transform healthcare, in line with the goals of the Military Medical Research and Development program. No sub-awards were indicated.
Generated 2/6/24, 7:24 AM